Diamyd Logo
This website is only intended for investors

Diamyd Medical − fighting pain and diabetes

Diamyd Medical is a Swedish pharmaceutical company focusing on the development of pharmaceuticals for treatment of pain and autoimmune diabetes. The Company was founded in 1996 and is headquartered in Stockholm, Sweden, with a subsidiary, Diamyd Inc., in Pittsburgh, USA.
Pain is a common complication of cancer, diabetes and other diseases. Our research in pain is based on the Nerve Targeting Drug Delivery System - NTDDS.
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
January 25, 2012 08:30 AM
Quarterly Report I 11/12